Zhao: Treatments Associated with Lower Mortality among Critically Ill COVID-19 Patients: A Retrospective Cohort Study

All Studies Meta Analysis

▶

All Studies Meta Analysis Recent:

Download Image

Zhao, 2,070 patient aspirin late treatment study: 43% lower mortality [p=0.0006] https://c19p.org/zhao5

copied to clipboard

Treatments Associated with Lower Mortality among Critically Ill COVID-19 Patients: A Retrospective Cohort Study

Zhao et al., Anesthesiology, doi:10.1097/ALN.0000000000003999

1 Oct 2021 Source PDF Share Tweet

Retrospective 2,070 hospitalized patients in the USA, showing lower mortality with aspirin treatment.

Important missing comments or errors? Let us know.

risk of death, 43.0% lower, HR 0.57, p < 0.001, treatment 121 of 473 (25.6%), control 140 of 473 (29.6%), adjusted per study, PSM.

risk of death, 28.0% lower, HR 0.72, p = 0.03, treatment 473, control 1,597, adjusted per study, multivariable.

Effect extraction follows pre-specified rules prioritizing more serious outcomes. Submit updates

Zhao et al., 1 Oct 2021, retrospective, USA, peer-reviewed, 6 authors.

All Studies Meta Analysis Submit Updates or Corrections

This Paper Aspirin All

Late treatment
is less effective

Please send us corrections, updates, or comments. Vaccines and treatments are complementary. All practical, effective, and safe means should be used based on risk/benefit analysis. No treatment, vaccine, or intervention is 100% available and effective for all current and future variants. We do not provide medical advice. Before taking any medication, consult a qualified physician who can provide personalized advice and details of risks and benefits based on your medical history and situation. FLCCC and WCH provide treatment protocols.

Submit